These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27752225)

  • 21. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics.
    Sharma D; Singh G; Kumar D; Singh M
    J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
    Comoglu T; Unal B
    Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast disintegrating tablets: Opportunity in drug delivery system.
    Parkash V; Maan S; Deepika ; Yadav SK; Hemlata ; Jogpal V
    J Adv Pharm Technol Res; 2011 Oct; 2(4):223-35. PubMed ID: 22247889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics.
    Sharma D; Singh M; Kumar D; Singh G
    J Pharm (Cairo); 2014; 2014():808167. PubMed ID: 26556203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral disintegration films: applications and production methods.
    Palezi SC; Fernandes SS; Martins VG
    J Food Sci Technol; 2023 Oct; 60(10):2539-2548. PubMed ID: 37599841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
    Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
    Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
    Al-khattawi A; Mohammed AR
    Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films.
    Ṣen Karaman D; Patrignani G; Rosqvist E; Smått JH; Orłowska A; Mustafa R; Preis M; Rosenholm JM
    Eur J Pharm Sci; 2018 Sep; 122():152-159. PubMed ID: 29966736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook.
    Elwerfalli AM; Ghanchi Z; Rashid F; Alany RG; ElShaer A
    Curr Drug Deliv; 2015; 12(6):652-67. PubMed ID: 25760951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The technologies used for developing orally disintegrating tablets: a review.
    Badgujar BP; Mundada AS
    Acta Pharm; 2011 Jun; 61(2):117-39. PubMed ID: 21684842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
    Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
    Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral disintegrating tablets. A new, modern, solid dosage form].
    Popa G; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catechin/β-cyclodextrin complex modulates physicochemical properties of pre-gelatinized starch-based orally disintegrating films.
    Sha H; Cui B; Yuan C; Li Y; Guo L; Liu P; Wu Z
    Int J Biol Macromol; 2022 Jan; 195():124-131. PubMed ID: 34896463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
    Song Q; Guo X; Sun Y; Yang M
    AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to assess orodispersible film quality? A review of applied methods and their modifications.
    Wasilewska K; Winnicka K
    Acta Pharm; 2019 Jun; 69(2):155-176. PubMed ID: 31259725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Orally disintegrating tablets--advantages and drawbacks].
    Tho I
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):424-5. PubMed ID: 22353836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orodispersible Films: Current Innovations and Emerging Trends.
    Jacob S; Boddu SHS; Bhandare R; Ahmad SS; Nair AB
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
    Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
    Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.